JNRBM

unofficial impact factor 1.10

Open Access Research

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis

Edward J Hollox1*, Jane Davies2,3, Uta Griesenbach2, Juliana Burgess4, Eric WFW Alton2 and John AL Armour1

Author Affiliations

1 Institute of Genetics, University of Nottingham, Nottingham, UK

2 Department of Gene Therapy, Faculty of Medicine at the National Heart and Lung Institute, Imperial College, London, UK

3 Paediatric Respiratory Disease, Royal Brompton Hospital, London, UK

4 Adult Cystic Fibrosis, Royal Brompton Hospital, London, UK

For all author emails, please log on.

Journal of Negative Results in BioMedicine 2005, 4:9 doi:10.1186/1477-5751-4-9

Published: 7 December 2005

Abstract

Human beta-defensin 2 (DEFB4, also known as DEFB2 or hBD-2) is a salt-sensitive antimicrobial protein that is expressed in lung epithelia. Previous work has shown that it is encoded in a cluster of beta-defensin genes at 8p23.1, which varies in copy number between 2 and 12 in different individuals. We determined the copy number of this locus in 355 patients with cystic fibrosis (CF), and tested for correlation between beta-defensin cluster genomic copy number and lung disease associated with CF. No significant association was found.